Study Investigator News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024

MIAMI (BUSINESS WIRE) Jun 1, 2024

United statesFlorida international universityJim footeDavid pattiCommunity foundation of browardBiomarker developmentScottr mackenzie foundationCorneliat bailey foundationNational institute of minority health disparitiesClinical laboratory improvement amendmentAmerican society of clinical oncologyAscent biomedicalFunctional precision medicineClinical oncologyFirst ascentClinical utility

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUptal patelMorgan warnersCaroline fryClinical researchEuropean renal associationAachen universityHuman immunology biosciences incImmunology biosciencesStudy investigatorChief medical officerMonograph capitalAlpha wave globalArkin bio capitalJeito capital

Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™

Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0001) through six months, with.

United statesRabia gurses ozdenDonald notmanPravin dugelMark gallardoJoyce allaireExchange commissionAmerican society of cataractOcular therapeutix incIntraocular pressureRetinal disease highlightedRefractive surgeryChief medical officerStudy investigatorGlaucoma specialistTravoprost intracameral implant

Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting

Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMark gallardoRabia gurses ozdenPravin dugelExchange commissionAmerican society of cataractOcular therapeutix incInvestorsocular therapeutix inc donald notmanchief financialIntraocular pressureRetinal disease highlightedRefractive surgeryChief medical officerStudy investigatorGlaucoma specialistTravoprost intracameral implantOpen angle glaucoma

Ocular Therapeutixtm Announces Positive Phase 2 PAXTRAVATM Glaucoma Data At The American Society Of Cataract And Refractive Surgery 2024 Annual Meetin

Ocular Therapeutixtm Announces Positive Phase 2 PAXTRAVATM Glaucoma Data At The American Society Of Cataract And Refractive Surgery 2024 Annual Meetin
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Pravin dugelMark gallardoJoyce allaireRabia gurses ozdenDonald notmanOcular therapeutix incExchange commissionIntraocular pressureChief medical officerStudy investigatorGlaucoma specialistTravoprost intracameral implantOpen angle glaucomaOcular hypertensionRetinal disease highlightedExecutive chairman